Max Planck Institute - for neurobiology of behavior — caesar

Press Release

Profitable exit: KonTEM trade sale to FEI Company (NASDAQ: FEIC)

22 May 2014 at 08:24

Joint press release by High-Tech Gruenderfonds (HTGF), Max Planck Innovation GmbH and research centre caesar

Bonn, 22nd May 2014: KonTEM GmbH, an HTGF-financed spin-off of the Max Planck Society and the research centre caesar, was taken over by FEI Company on a share deal basis. Thus the phase contrast technology developed by KonTEM is absorbed in the portfolio of a globally operating market leader in the field of high-performance microscopy workflow solutions.

The phase contrast system for transmission electron microscopy (TEM) developed by KonTEM enables a two to three times better image contrast without compromising resolution, hence opening up new possibilities for the examination of biological samples in the technological border area.

The research on the underlying technology was conducted at the Max Planck Institute for Biophysics in Frankfurt and further development at caesar turned it into a marketable product which is currently in the customer test period. “KonTEM exemplifies that fundamental research as it is conducted by the Max Planck Society can be the basis for innovative and market-driven products”, says Dr. Florian Kirschenhofer, Startup Manager at Max-Planck-Innovation, Max Planck's technology transfer organization.

The technology and the company were prized on several occasions, for example with the highest award of the NUK business plan competition in 2011 and the Innovation Award of the cooperative bank Volksbank Bonn Rhein-Sieg in 2012. Prof. Dr. U. Benjamin Kaupp, Scientific Director at caesar: “The acquisition by an industry leader like FEI shows that KonTEM disposes of an extraordinary and future-oriented technology.”

The M&A mandate for the successful exit was carried out by HTGF. Dr. Andreas Olmes, Investment Director: “We are very happy for the buyer as well as for the KonTEM management. KonTEM’s proprietary phase contrast technology has found a great new home with FEI.”

About caesar foundation
The caesar foundation is associated with the Max Planck Society and operates a centre for neuroscientific research in Bonn. It disposes of high resolution and analytical (cryo-) electron microscopes for structure determination, spectroscopy and nanostructuring. The scientific work is carried out according to the Max Planck Society’s criteria of excellence. More press releases and photographs can also be found on the internet under: www.caesar.de.

For further information please contact:

Also interesting:

newstype__news

23 Mar 2026

Atlanta Science Festival 2026

Sunshine, crowded pathways, and a long line in front of our booth: at the Atlanta Science Festival, neurobiology became a hands-on experience for many visitors. Through interactive experiments and a great deal of curiosity, a lively exchange emerged between research and the public.

keepreading

newstype__news

15 Mar 2026

Young minds explore the brain: DNO 2026

More than 60 students gathered at the Max Planck Institute for Neurobiology of Behavior caesar in Bonn for the 2026 German Neuroscience Olympiad. Across written and practical challenges, they explored how the brain works, from neuroanatomy to clinical case studies.

The event combined competition with hands-on experiences and direct exchange with researchers, offering participants a unique insight into the world of neuroscience.

keepreading

newstype__news

3 Mar 2026

Dori Grijseels receives 2026 ALBA-FKNE Diversity Prize

Postdoctoral researcher Dori Grijseels has received the 2026 ALBA-FKNE Diversity Prize, recognising their international efforts to advance equity and inclusion for LGBTQIA+ scientists in brain research.

keepreading